www.reuters.com
Open in
urlscan Pro
2600:9000:2009:5200:15:5a3e:9d40:93a1
Public Scan
URL:
https://www.reuters.com/business/healthcare-pharmaceuticals/covid-remains-public-health-emergency-says-who-2023-01-30/
Submission: On December 04 via api from US — Scanned from US
Submission: On December 04 via api from US — Scanned from US
Form analysis
0 forms found in the DOMText Content
Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv * World Browse World * Africa * Americas * Asia Pacific * China * Europe * India * Israel and Hamas at War * Japan * Middle East * Ukraine and Russia at War * United Kingdom * United States * Reuters NEXT * US Election * Business Browse Business * Aerospace & Defense * Autos & Transportation * Davos * Energy * Environment * Finance * Healthcare & Pharmaceuticals * Media & Telecom * Retail & Consumer * Future of Health * Future of Money * Take Five * World at Work * Markets Browse Markets * Asian Markets * Carbon Markets * Commodities * Currencies * Deals * Emerging Markets * ETFs * European Markets * Funds * Global Market Data * Rates & Bonds * Stocks * U.S. Markets * Wealth * Macro Matters * Sustainability Browse Sustainability * Boards, Policy & Regulation * Climate & Energy * Land Use & Biodiversity * Society & Equity * Sustainable Finance & Reporting * The Switch * Reuters Impact * COP29 * Legal Browse Legal * Government * Legal Industry * Litigation * Transactional * US Supreme Court * Breakingviews Browse Breakingviews * Breakingviews Predictions * Technology Browse Technology * Artificial Intelligence * Cybersecurity * Space * Disrupted * More Investigations Sports * Athletics * Baseball * Basketball * Cricket * Cycling * Formula 1 * Golf * NFL * NHL * Soccer * Tennis Science Lifestyle Graphics Pictures Wider Image Podcasts Fact Check Video Sponsored Content * Reuters Plus * Press Releases Live My News Sign InSubscribe WHO MAINTAINS HIGHEST ALERT OVER COVID, BUT SEES HOPE AHEAD By Reuters January 30, 20236:45 AM HSTUpdated 2 years ago Text * Small Text * Medium Text * Large Text Share * X * Facebook * Linkedin * Email * Link A nurse prepares a shot for Jonathan Halter as the German embassy begins its roll out of BioNTech COVID-19 vaccines for German expatriates at a Beijing United Family hospital in Beijing, China January 5, 2023. REUTERS/Thomas Peter/File Photo Purchase Licensing Rights, opens new tab Jan 30 (Reuters) - The World Health Organization (WHO) said on Monday that COVID-19 continues to constitute a public health emergency of international concern, its highest form of alert. The pandemic was likely in a "transition point" that continues to need careful management to "mitigate the potential negative consequences", the agency added in a statement. It is three years since the WHO first declared that COVID represented a global health emergency. More than 6.8 million people have died during the outbreak, which has touched every country on Earth, ravaging communities and economies. Advertisement · Scroll to continue Report this ad However, the advent of vaccines and treatments has changed the pandemic situation considerably since 2020, and WHO Director-General Tedros Adhanom Ghebreyesus has said he hopes to see an end to the emergency this year, particularly if access to the counter-measures can be improved globally. "We remain hopeful that in the coming year, the world will transition to a new phase in which we reduce (COVID) hospitalisations and deaths to their lowest possible level,” Tedros told a separate WHO meeting on Monday. Advertisement · Scroll to continue Advisers to the WHO expert committee on the pandemic's status told Reuters in December that it was likely not the moment to end the emergency given the uncertainty over the wave of infections in China after it lifted its strict zero-COVID measures at the end of 2022. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here. Reporting by Abinaya Vijayaraghavan in Bengaluru and Jennifer Rigby in London; Editing by Toby Chopra and Nick Macfie Our Standards: The Thomson Reuters Trust Principles., opens new tab * Suggested Topics: * Healthcare & Pharmaceuticals * COVID-19 * Regulatory Oversight * Government Health Policy * Lawsuits Share * X * Facebook * Linkedin * Email * Link Purchase Licensing Rights READ NEXT * Healthcare & PharmaceuticalscategoryExclusive: Big hedge funds call on doctors, scientists for an edge on pharma * Healthcare & PharmaceuticalscategoryNovavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln * California suspends Raw Farm's raw milk products after bird flu detection * Retail & ConsumercategoryE. coli outbreak tied to McDonald's Quarter Pounders has ended, CDC says * Healthcare & PharmaceuticalscategoryHumana CFO Susan Diamond to step down in latest management change * Healthcare & PharmaceuticalscategoryUnitedHealth forecasts 2025 profit largely in line with estimates BUSINESS * EURO ZONE BUSINESS ACTIVITY DECLINES SHARPLY IN NOVEMBER, PMI SHOWS category · December 3, 2024 · 11:05 PM HST · 13 min ago Business activity across the euro zone fell sharply last month as the bloc's dominant services sector joined the manufacturing sector in contracting, according to a survey which showed a broadbased decline. * BusinesscategoryGerman firms' China market sentiment falls to record low, survey shows11:04 PM HST · Updated 14 min ago * MarketscategoryOECD warns of protectionism risk to global growth outlook11:03 PM HST · Updated 15 min ago * Autos & TransportationcategoryStellantis denies report about picking Apple's Maestri as new CEO11:03 PM HST · Updated 15 min ago * Healthcare & PharmaceuticalscategoryNovavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln11:00 PM HST · Updated 18 min ago SITE INDEX LATEST * Home * Authors * Topic Sitemap * Archive * Article Sitemap BROWSE * World * Business * Markets * Sustainability * Legal * Breakingviews * Technology * Investigations * Sports * Science * Lifestyle MEDIA * Videos * Pictures * Graphics * Podcasts ABOUT REUTERS * About Reuters, opens new tab * Advertise with Us, opens new tab * Careers, opens new tab * Reuters News Agency, opens new tab * Brand Attribution Guidelines, opens new tab * Reuters and AI, opens new tab * Reuters Leadership, opens new tab * Reuters Fact Check * Reuters Diversity Report, opens new tab STAY INFORMED * Download the App (iOS), opens new tab * Download the App (Android), opens new tab * Newsletters INFORMATION YOU CAN TRUST Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. FOLLOW US * X * Facebook * Instagram * Youtube * Linkedin THOMSON REUTERS PRODUCTS * WESTLAW, OPENS NEW TAB BUILD THE STRONGEST ARGUMENT RELYING ON AUTHORITATIVE CONTENT, ATTORNEY-EDITOR EXPERTISE, AND INDUSTRY DEFINING TECHNOLOGY. * ONESOURCE, OPENS NEW TAB THE MOST COMPREHENSIVE SOLUTION TO MANAGE ALL YOUR COMPLEX AND EVER-EXPANDING TAX AND COMPLIANCE NEEDS. * CHECKPOINT, OPENS NEW TAB THE INDUSTRY LEADER FOR ONLINE INFORMATION FOR TAX, ACCOUNTING AND FINANCE PROFESSIONALS. LSEG PRODUCTS * WORKSPACE, OPENS NEW TAB ACCESS UNMATCHED FINANCIAL DATA, NEWS AND CONTENT IN A HIGHLY-CUSTOMISED WORKFLOW EXPERIENCE ON DESKTOP, WEB AND MOBILE. * DATA CATALOGUE, OPENS NEW TAB BROWSE AN UNRIVALLED PORTFOLIO OF REAL-TIME AND HISTORICAL MARKET DATA AND INSIGHTS FROM WORLDWIDE SOURCES AND EXPERTS. * WORLD-CHECK, OPENS NEW TAB SCREEN FOR HEIGHTENED RISK INDIVIDUAL AND ENTITIES GLOBALLY TO HELP UNCOVER HIDDEN RISKS IN BUSINESS RELATIONSHIPS AND HUMAN NETWORKS. * Advertise With Us, opens new tab * Advertising Guidelines * Purchase Licensing Rights, opens new tab * Cookies, opens new tab * Terms of Use * Privacy, opens new tab * Digital Accessibility, opens new tab * Corrections * Site Feedback, opens new tab All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2024 Reuters. All rights reserved